[go: up one dir, main page]

RU99125410A - METHOD FOR TREATING CHRONIC VIRAL HEPATITIS - Google Patents

METHOD FOR TREATING CHRONIC VIRAL HEPATITIS

Info

Publication number
RU99125410A
RU99125410A RU99125410/14A RU99125410A RU99125410A RU 99125410 A RU99125410 A RU 99125410A RU 99125410/14 A RU99125410/14 A RU 99125410/14A RU 99125410 A RU99125410 A RU 99125410A RU 99125410 A RU99125410 A RU 99125410A
Authority
RU
Russia
Prior art keywords
viral hepatitis
chronic viral
treating chronic
treatment
interferon
Prior art date
Application number
RU99125410/14A
Other languages
Russian (ru)
Other versions
RU2180862C2 (en
Inventor
Михаил Аркадьевич Колпаков
Михаил Семенович Любарский
Юлия Валерьевна Башкирова
Андрей Иванович Шевела
Сергей Алексеевич Мордвов
Сергей Александрович Спарин
Original Assignee
Научно-исследовательский институт клинической и экспериментальной лимфологии СО РАМН
Filing date
Publication date
Application filed by Научно-исследовательский институт клинической и экспериментальной лимфологии СО РАМН filed Critical Научно-исследовательский институт клинической и экспериментальной лимфологии СО РАМН
Priority to RU99125410A priority Critical patent/RU2180862C2/en
Priority claimed from RU99125410A external-priority patent/RU2180862C2/en
Publication of RU99125410A publication Critical patent/RU99125410A/en
Application granted granted Critical
Publication of RU2180862C2 publication Critical patent/RU2180862C2/en

Links

Claims (1)

Способ лечения хронических вирусных гепатитов, заключающийся в введении противовирусного препарата, отличающийся тем, что через катетер в круглой связке печени вводится интерферон в дозе 3000000 ЕД через день в течение двух недель, курс лечения повторяют 3 раза с интервалом в 3 месяца.A method for the treatment of chronic viral hepatitis, which consists in the introduction of an antiviral drug, characterized in that interferon is introduced through a catheter in a round ligament of the liver at a dose of 3,000,000 units every other day for two weeks, the treatment is repeated 3 times with an interval of 3 months.
RU99125410A 1999-11-30 1999-11-30 Method to treat chronic viral hepatitis RU2180862C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU99125410A RU2180862C2 (en) 1999-11-30 1999-11-30 Method to treat chronic viral hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU99125410A RU2180862C2 (en) 1999-11-30 1999-11-30 Method to treat chronic viral hepatitis

Publications (2)

Publication Number Publication Date
RU99125410A true RU99125410A (en) 2001-08-27
RU2180862C2 RU2180862C2 (en) 2002-03-27

Family

ID=20227658

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99125410A RU2180862C2 (en) 1999-11-30 1999-11-30 Method to treat chronic viral hepatitis

Country Status (1)

Country Link
RU (1) RU2180862C2 (en)

Similar Documents

Publication Publication Date Title
DK1001801T3 (en) Product comprising at least one double-chain RNA combined with at least one interferon for the treatment of viral hepatitis
HK1068548A1 (en) Use of omega interferon in the manufacture of a medicament for treating hepatitis c
DK0911033T4 (en) Use of consensus interferon to reduce the side effects of interferon therapy in viral hepatitis
DK0858343T3 (en) Continuous low dose cytokine infusion therapy
TWI317735B (en) Methods and compositions for treating hepatitis c virus
HK1037981A1 (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis C.
DE69901321D1 (en) Combination therapy containing ribavirin and interferon alpha in patients with chronic hepatitis C infection who have not been previously treated with antiviral drugs
HK1084862A1 (en) Use of omega interferon in the manufacturing of a medicament for treating viral disease in a warm-blooded animal subject
ID27290A (en) USE OF 1,5-DIDEOKSI-1,5-IMINO-D-GLUSITOL-N-SUBSTITUTED N-COMPOUND IN TREATMENT OF HEPATITIC VIRUS INFECTION
IL134345A0 (en) Methods for treatment of patients afflicted with multiple sclerosis using consensus interferon
DE69830241D1 (en) USE OF N-SUBSTITUTED 1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL COMPOUNDS IN COMBINATION THERAPY OF INFECTIONS CAUSED BY HEPATITISVIRUS
NO911429D0 (en) DRUG TREATMENT.
RU99125410A (en) METHOD FOR TREATING CHRONIC VIRAL HEPATITIS
NO911430D0 (en) DRUG TREATMENT.
CY1106388T1 (en) THERAPY OF HEPATITIS C WITH THYMOSIN, INTEPHON, AND RIBAVIRIN
DK1311286T3 (en) Treatment of hepatitis C with thymosin and pegylated interferon
Klein Does your liver quiver? Hepatitis C and HIV
James Ribavirin approved for hepatitis C combination treatment
RU98121717A (en) METHOD FOR TREATING ALLERGIC DISEASES
RU99119123A (en) METHOD FOR TREATING CHRONIC VIRAL HEPATITIS
RU99121095A (en) METHOD FOR TREATING HEMOPHILIC ARTHROPATHY
ES2051788T3 (en) A PHARMACEUTICAL PRODUCT.
RU99118112A (en) METHOD FOR TREATING PATIENTS WITH NEUROTIC DISORDERS, MYELOPID
RU98103406A (en) METHOD FOR TREATING VIBRATIONAL DISEASE
UA38888A (en) Method for treating chronic viral hepatitis